Biofrontera AG enters into exclusive license agreement with Maruho Co., Ltd.
April 20, 2020 04:20 ET
|
Biofrontera AG
Leverkusen, Germany, April 20, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (“Biofrontera” or the “Company”), an international biopharmaceutical company, has...
Dermavant Enters into Exclusive License Agreement with JT for Development and Commercialization of Tapinarof in Japan
January 15, 2020 02:39 ET
|
Dermavant Sciences, Inc.
JT and its subsidiary, Torii Pharmaceutical, receive rights to develop and commercialize tapinarof for psoriasis and atopic dermatitis in Japan Dermavant to receive an upfront payment of $60 million,...
Onconova Therapeutics Announces Exclusive License Agreement with Specialised Therapeutics for Rigosertib in Australia and New Zealand
December 18, 2019 09:00 ET
|
Onconova Therapeutics, Inc.
Specialised Therapeutics receives exclusive license to commercialize rigosertib in Australia and New ZealandOnconova to be eligible to receive up to US $30.4 million in clinical, regulatory, and...
Yield10 Bioscience Signs Research Agreement with J. R. Simplot to Evaluate New Traits to Produce High Yielding, Sustainable Potato Crop
October 23, 2019 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) today announced that it has signed a research agreement with Boise, Idaho-based J. R. Simplot Company, to...
Co-Diagnostics, Inc. and LGC, Biosearch Technologies Expand License Agreement for CoPrimer™ Technology
September 04, 2019 06:30 ET
|
Co-Diagnostics
Salt Lake City, Utah, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Diagnostics,” or the “Company”), a molecular diagnostics company with a unique, patented platform...
PROCESSA PHARMACEUTICALS ANNOUNCES THE LICENSING OF AN ANTI-FIBROTIC, ANTI-INFLAMMATORY DRUG FOR THE TREATMENT OF MULTIPLE UNMET MEDICAL NEED CONDITIONS
September 03, 2019 09:30 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (OTCQB: PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of...
American International Holdings Corp Executes Exclusive License Agreement to Establish Novopelle Locations Worldwide
July 05, 2019 09:00 ET
|
American International Holdings Corp.
HOUSTON, TX, July 05, 2019 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTC: AMIH, or the “Company”) is pleased to announce that it has entered into an exclusive, irrevocable license...
Vivos Inc. Enhances its Intellectual Property Protection
July 02, 2019 07:00 ET
|
Vivos Inc.
Richland WA, July 02, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGLD), Vivos today announced the filing of a patent application covering key aspects of its technology and propriety...
Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals to Develop and Commercialize Rigosertib in Greater China
May 13, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
Onconova to Receive $4 Million Upfront, including $2 Million Fee and $2 Million for Onconova Shares Purchased at a Premium, Plus up to $45.5 Million in Regulatory and Sales Milestones for Rigosertib...
Singing Machine Signs License Agreement with Talpa Global for ‘The Voice’
April 09, 2019 09:00 ET
|
The Singing Machine Company, Inc.
Singing Machine and Talpa partner to create ‘The Voice Karaoke’ consumer products Fort Lauderdale, FL, April 09, 2019 (GLOBE NEWSWIRE) -- The Singing Machine Company, Inc. (“Singing Machine” or...